FDA Cleared
New Device
Pathway: 510K
SEEG-Tx® System (STX-SYS-001)
Applicant:
Dixi Medical
Statutory Profile
Legal Standard:
Substantial Equivalence (SE) to predicate (21 CFR 807)
Product Code:
GXD
Review Panel:
Neurology
21 CFR Regulation:
8
Review Velocity Metrics
Date Received:
2026-02-02
Decision Date:
2026-10-29
Total Review Duration:
269 calendar days (269 days)
Official FDA Research Backlinks
Direct links to primary official records hosted by the U.S. Food and Drug Administration CDRH databases:
Identified Contacts & Correspondents
Lucie PETEGNIEF
Role: SUBMITTER_CONTACT
Notice a discrepancy or outdated information on this record?
Report to support@fdacleared.org